TOPLINE: Ultrahypofractionated radiotherapy demonstrated non-inferiority to conventional fractionation with higher 10-year failure-free survival with similar toxicity profiles in patients with intermediate- or high-risk localised prostate cancer. […]

TOPLINE: A cohort study found that commonly prescribed medications did not seem to affect treatment outcomes in veterans with stage IV non-small cell lung cancer (NSCLC) […]